Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05031429 · ClinicalTrials.gov registry record · NA
Time Limited Eating in Type 1 Diabetes
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05031429 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 12 participants.
The verdict
NCT05031429, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is a randomized-control pilot study that aims to evaluate Time Limited Eating (TLE) in the pediatric T1D population, implemented within the first six months after diagnosis. This period is characterized by residual β-cell function, during which TLE may have the ability to preserve and improve β-cell activity, indicated by increased C-peptide production. The investigators aim to assess the feasibility, acceptability, and safety of TLE in the pediatric T1D population, as well as to investigate the impact of TLE on β-cell function, insulin sensitivity, and glycemic control.
Interventions
- OTHER Time Limited Eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05031429
The ClinicalTrials.gov registry entry for NCT05031429 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Time Limited Eating is the first listed.
NCT05031429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05031429 about?
NCT05031429 is a clinical study titled "Time Limited Eating in Type 1 Diabetes". This study is a randomized-control pilot study that aims to evaluate Time Limited Eating (TLE) in the pediatric T1D population, implemented within the first six months after diagnosis. This period is characterized by residual β-cell function, during which TLE may have the ability to preserve and imp...
What is the current status of trial NCT05031429?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-01-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05031429?
The interventions under investigation include: Time Limited Eating (OTHER).
Who is sponsoring clinical trial NCT05031429?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.